Finance

Beta
Lists
9594:TADAWUL
Al-Modawat Specialized Medical Co SJSC
SAR 5.70
+1.24%
(+0.070) 1D
Jun 10, 3:10:10 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 9594...
Open
SAR 5.54
High
SAR 5.96
Low
SAR 5.54
Mkt. cap
406.12M
Avg. vol.
111.65K
Volume
34.05K
Dividend
2.63%
Quarterly dividend
SAR 0.04
Ex-dividend date
Aug 17, 2026
P/E ratio
24.75
52-wk high
SAR 7.00
52-wk low
SAR 3.06
EPS
SAR 0.23
Shares outstanding
32.82M
Open
SAR 5.54
High
SAR 5.96
Low
SAR 5.54
Mkt. cap
406.12M
Avg. vol.
111.65K
Volume
34.05K
Dividend
2.63%
Quarterly dividend
SAR 0.04
Ex-dividend date
Aug 17, 2026
P/E ratio
24.75
52-wk high
SAR 7.00
52-wk low
SAR 3.06
EPS
SAR 0.23
Shares outstanding
32.82M
News stories
From sources across the web
About Al-Modawat Specialized Medical Co SJSC
CEO-
Employees-
Founded2014
Headquarters-
SectorHealth care provider
Websitealmodawat.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
26.54M
29.40M
37.20M
34.91M
Cost of goods sold
14.42M
17.10M
23.14M
20.45M
Cost of revenue
14.42M
17.10M
23.14M
20.45M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.79M
8.05M
1.70M
10.51M
Operating expense
6.79M
8.05M
5.54M
10.51M
Total operating expenses
21.21M
25.16M
28.68M
30.96M
Operating income
5.33M
4.25M
8.52M
3.95M
Other non operating income
102.90K
253.18K
-1.50M
131.60K
EBT including unusual items
5.03M
3.96M
5.67M
3.07M
EBT excluding unusual items
4.94M
3.96M
6.33M
3.07M
Income tax expense
209.98K
263.48K
650.30K
199.90K
Effective tax rate
4.17%
6.65%
11.48%
6.50%
Other operating expenses
-
-
396.64K
-
Net income
4.82M
3.70M
5.02M
2.87M
Net profit margin
18.16%
12.59%
13.48%
8.23%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-495.18K
-534.78K
-688.78K
-1.00M
Net interest expenses
-495.18K
-534.78K
-688.78K
-1.00M
Depreciation and amortization charges
-
-
1.76M
-
EBITDA
6.25M
5.22M
9.54M
3.95M
Gain or loss from assets sale
-
54.68K
72.42K
1.23M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer